Experienced life science and drug development business professional with 15+ years in business development and strategy, commercial market research, data and financial analytics, and project management. Passion for driving the advancement of promising scientific research and great technologies towards development and commercialization through working in the interface of science and business, to make a difference for patients and doctors. Successfully completed licensing, investing, and other transactions with total deal value >$1B. Selected examples: - Raised $40M Series A from cross-Pacific syndicate of leading life science investors to create new Chinese JV company, anchored with Chinook's leading pipeline in kidney disease precision medicines - Acquired Phase 3 oncology drug for minimal upfront and back-end deal value [Sierra has since been acquired for $1.9B after positive data readout] Experienced life science and drug development business professional with 15+ years in business development and strategy, commercial market research, data and financial analytics, and project management. Passion for driving the advancement of promising scientific research and great technologies towards development and commercialization through working in the interface of science and business, to make a difference for patients and doctors. Successfully completed licensing, investing, and other transactions with total deal value >$1B. Selected examples: - Raised $40M Series A from cross-Pacific syndicate of leading life science investors to create new Chinese JV company, anchored with Chinook's leading pipeline in kidney disease precision medicines - Acquired Phase 3 oncology drug for minimal upfront and back-end deal value [Sierra has since been acquired for $1.9B after positive data readout]

• 

  Principal in Amplitude Ventures

  We stand proudly on a foundation of deep experience and a demonstrable body of success creating, building, and growing break-out companies.|